Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights include treatment changes for longer survival in pancreatic cancer and colorectal cancer.
ASCO Annual Meeting 2018: Geriatric Assessment Improves Communication, Racial and Gender Differences in Cancer Treatment, and a Comparison of Cancer Treatment Costs
Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights include the effects of geriatric assessment on patient-doctor communication, treatments for advanced prostate cancer that may work better in black men, the possibility that women are undertreated for head and neck cancer, and a comparison of treatment costs for colorectal cancer between the U.S. and Canada.
Being diagnosed with colorectal cancer can be scary and confusing. Dr. Jeffrey Meyerhardt, an expert in colorectal cancer, describes the 4 questions that any newly diagnosed patient should ask.
The 2018 Cancer Survivorship Symposium: Advancing Care and Research will address key issues in promoting well-being in people who have finished active cancer treatment, covering topics such as exercise, follow-up care in young adult survivors, and better support for sexual problems.
One of the studies that will be presented at the Gastrointestinal Cancers Symposium this week has found that a liquid biopsy test can accurately find early-stage colorectal cancer.
In this podcast, Dr. Noelle LoConte discusses a recent statement from the American Society of Clinical Oncology that covers the link between drinking alcohol and developing cancer.
Cancer.Net’s Associate Editors discuss the most exciting research presented at the 2017 ASCO Annual Meeting.
ASCO Annual Meeting 2017: Symptom Reporting Extends Lives, Shorter Chemotherapy for Some Colon Cancer Patients, and Targeted Therapy in BRCA-Related Breast Cancer
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research released today covers how using a web-based system to report symptoms helps patients live longer, a shorter schedule of chemotherapy can be an option for certain people with colon cancer, and a targeted therapy may slow the growth of BRCA-related breast cancer.